The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied in laboratory research examining melanocortin signaling pathways and neuropeptide receptor interactions.